News
News Update from Cancer Research UK - Stories from Before Lockdown
06/07/20
We know the world has turned a bit upside down recently, so we've rounded up some positive cancer research stories from before lockdown that we haven't had the chance to share with you yet. From a new treatment for breast cancer being approved, to understanding pancreatic cancer, there's lots to catch up on…
NICE rejection of use of Abiraterone for men with newly-diagnosed metastatic prostate cancer in England and Wales
06/07/20
You may have already found out that a recent decision has been made by NICE not to approve the use of abiraterone as an additional treatment with hormone therapy in men newly diagnosed with advanced prostate cancer in England and Wales. This was being appraised as an alternative to the current standard of treatment regime which combines hormone therapy and docetaxel…
Mens Health Forum - Features Mens Health Week 16th - 20th June 2020
17/06/20
Mens Health Forum have special features on their website for Mens Health Week 16th - 21st June 2020, timed for the run-up to Fathers day. A key message on the website about the virus is "Men are Twice as Likely to Die"…
Staying In Quiz hosted by Stephen Fry, Bill Turnbull Wednesday 17th June at 8pm
16/06/20
Jeff Stelling, Gemma Oaten and many more host a star-studded quiz to raise money for prostate cancer research that's now at risk due to lack of funding. PCUK says "we won’t be returning to our local for a little while, so let the pub quiz fun come to you…
At Home with Bill Turnbull - Watch the Video on the PCUK website
16/06/20
Bill Turnbull has made a video for Prostate Cancer UK in which he discusses life under lockdown, his dogs and his bees in context of his battle with advanced Prostate Cancer. Bill had left his job as Breakfast TV presenter some time ago and discovered he had Prostate Cancer. He is now working as a presenter on Classic FM and as an ambassador for Prostate Cancer UK…
Prostate becomes the most common Cancer in the UK - 10 Years Earlier than Predicted
04/06/20
Prostate cancer becomes the UK’s most commonly diagnosed cancer –
10 years earlier than predicted
Prostate cancer has become the UK’s most commonly diagnosed cancer for the first time, according to the latest¹ UK-wide statistics² shared by Prostate Cancer UK…
FDA Approves Olaparib for Treatment of Advanced Prostate Cancer - Prostate Cancer Research Centre Report
20/05/20
The Prostate Cancer Research Centre reports:
This has been a truly historic week, with two new treatment options receiving FDA approval for men with advanced prostate cancer. Today, olaparib was approved by the FDA for certain metastatic prostate cancers that are not responsive to hormone therapy. Just last Friday, another drug in the class referred to as PARP inhibitors, rucaparib, was also approved…
Hormone Therapy might protect men from COVID-19 - Research Blog from Prostate Cancer Foundation
11/05/20
Figures from our statisticians show that men are at higher rosk from Covid-19. The medical profession has concluded that Oestrogen can help in combatting the onset of Covid-19. This suggests that if you are currently on ADT (Androgen Deprivation Therapy) there might be the beneficial side-effect of increased protection against Covid…
PCRC Research - Why do Prostate Cancers become Resistant to Hormone Therapy?
07/05/20
Dr Luke Gaughan, one of PCRCs researchers, is investigating how prostate cancers become resistant to hormone therapy. This subject must be relevant to a number of members of our group. His team member, Dr Dominic Jones, had a teleconference with our Head of Research on Tuesday 21st April to update us on what they’ve managed to achieve in the first few months of their project, including what they’ve been doing to continue making progress whilst social distancing…
Pussycats and Tigers - PCRC wants to tell the difference
07/05/20
The Prostate Cancer Research Centre (PCRC) team led by Dr. Daniel Brewer is analysing a huge amount of molecular data collected from prostate cancer samples, to develop a new way to classify prostate cancer. This will mean that patients can receive personalised treatments based on the characteristics and behaviour of their individual cancer…